Invesco Mutual Fund increases stake in Corona Remedies Ltd
Invesco Mutual Fund has increased its holding in Corona Remedies Limited, reporting a total aggregate shareholding of 5.0562% of the paid-up share capital as of June 17, 2026.The investment vehicle holds shares across several funds, including Invesco India Consumption Fund, Invesco India Smallcap Fund, Invesco India Large & Mid Cap Fund, Invesco India Midcap Fund, and Invesco India Multicap Fund.
Before the acquisition under consideration, the acquirer’s holding stood at 4.5836%, comprising 2,803,355 shares carrying voting rights. The current transaction saw the acquisition of 2,89,017 shares, which equates to a rise of 0.4726%.
Following this acquisition, Invesco Mutual Fund’s total holding in Corona Remedies Limited reached 5.0562%, comprising 30,92,372 shares carrying voting rights. The acquiring entity is reported as not belonging to the promoter group.
Key figures regarding the shareholding status of Corona Remedies Limited are presented below:
| Metric | Before Acquisition (as on June 17, 2026) | After Acquisition (as on June 17, 2026) |
|---|---|---|
| Acquirer's Holding | 4.5836% | 5.0562% |
| Shares Held by Acquirer | 2,803,355 shares | 30,92,372 shares |
| Equity Share Capital (Total) | Rs. 61,16,00.880/- (6,11,60.088 equity shares of Rc. 10/- each) | Rs. 61,16,00,880/- (6,11,60.088 equity shares of Re. 10/- each) |
The acquisition was completed through the Open Market. The reported date of acquisition for the shares is June 17, 2026.
CORONA Stock Price Movement
Shares of CORONA Remedies Limited are edging higher to ₹1849.50 as of 10:55 AM today, climbing by 1.29% in live trading. The stock currently trades within an intraday range spanning from a low of ₹1809.30 to a high of ₹1853.50, with 12,199 shares exchanged so far.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.